期刊文献+

增效硫酸多黏菌素口服液治疗仔猪黄白痢临床试验 被引量:1

Clinical trials of efficiency sulfuric acid colistin oral on controlling yellow and white scour of piglet
下载PDF
导出
摘要 为验证增效多硫酸黏菌素口服液对仔猪黄白痢的临床疗效,选用自然感染仔猪黄白痢患病仔猪为试验对象,以硫酸多黏菌素口服液的疗效为对照。结果显示,增效硫酸多黏菌素口服液高、中、低剂量组对仔猪黄白痢的治愈率分别为90.0%、83.3%、53.3%,总有效率分别为93.3%、86.6%和76.6%;硫酸多黏菌素口服液对照组的治愈率为60.0%、总有效率为83.3%;试验药物高、中剂量组对仔猪黄白痢的治愈率与对照药物比较差异显著(P<0.05)。表明增效硫酸多黏菌素口服液对仔猪黄白痢的临床疗效显著优于硫酸多黏菌素口服液,建议推荐剂量为每次0.2mL/kg,每天2次,连用2d。 For verifying the clinical effects of efficiency sulfuric acid eolistin oral on controlling the yellow and white scour of piglets, natural sick piglets infected with yellow and white scour were selected for the test, and the piglets treated with sulfuric acid colistin were used as the control. The results showed that the cure rate of high, middle and low dosage groups of efficiency sulfuric acid colistin oral on the yellow and white scour of piglet was 90.0%, 83.3% and 53.3%, respectively, and the total effective rate was 93.3%, 86.6% and 76.6%, respectively, While that for sulfuric acid colistin oral was 60.0% and 83.3%, respectively. The difference of cure rate between the high group and the control group,the middle group and the control group was significant (P〈0.05). The results indicated that the effecte of efficiency sulfuric acid colistin oral on curing the yellow and white scour of piglet was better than that of the sulfuric acid colistin oral, and the suggested application dosage was 0.2 mL/kg for one time and twice everyday in two days.
出处 《广西农业科学》 CSCD 2009年第2期210-212,共3页 Guangxi Agricultural Sciences
关键词 增效硫酸多黏菌素 仔猪黄白痢 治愈率 efficiency sulfuric acid colistin yellow and white scour of piglets cure rate
  • 相关文献

参考文献8

二级参考文献46

  • 1鲍燕燕.抗生素的后效应[J].药学情报通讯,1989,7(4):24-25. 被引量:5
  • 2戴白英.实用抗菌素学[M].北京:人民卫生出版社,1977.265—269.
  • 3朱模忠.兽药手则[M].北京:化工出版社,2002.84—85.
  • 4陈杖榴.兽药药理学[M].北京:中国农业出版社,2002.225—226.
  • 5宋振玉.当代药理学[M].北京:协和出版社,1990.378—380.
  • 6Jian Li,Roger L,Nation Robert W,etal.Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria[J].Inter J Antimicro Agents,2005,25:11-25.
  • 7Stein A,Raoult D.Colistin:an antimicrobial for the 21 st century?[J].Clin Infect Dis,2002,35(7):901-902.
  • 8Garnacho-Montero J,Ortiz-Leyba C,Jim nez-Jim nez FJ,et al.Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VIP) with intravenous colistin:a comparison with imipenem-susceptible VAP[J].Clin Infect Dis,2003,36:1111-1118.
  • 9Reina R,Estenssoro E,Saenz G,et al.Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:a prospective cohort study[J].Intensive Care Med,2005,31(8):1058-1065.
  • 10Peter K.linden,Shimon Kusne,Kim Coley,et al.Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aerginasa[J].Clin Infect Dis,2003,37:154-160.

共引文献25

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部